Clinical Trial: An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Systemic Lupus Erythematosus
Lupus Nephritis
Study Type: INTERVENTIONAL
Official Title: An Open-label, Multi-center, Phase 1/2 Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Participants With Severe, Refractory Systemic Lupus Erythematosus
Brief Summary:
The study is intended to assess safety, efficacy and cellular kinetics of YTB323 treatment in participants with severe refractory systemic lupus erythematosus.
Read more